0002115406-26-000003.txt : 20260310 0002115406-26-000003.hdr.sgml : 20260310 20260310172453 ACCESSION NUMBER: 0002115406-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260310 DATE AS OF CHANGE: 20260310 EFFECTIVENESS DATE: 20260310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADVAC Therapeutics Inc CENTRAL INDEX KEY: 0002115406 ORGANIZATION NAME: EIN: 920484199 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-576078 FILM NUMBER: 26740592 BUSINESS ADDRESS: STREET 1: 1013 CENTRE ROAD, SUITE403-B STREET 2: SUITE 410 CITY: WILMINGTON STATE: OH ZIP: 19805 BUSINESS PHONE: 9082853087 MAIL ADDRESS: STREET 1: 2281 KENNY ROAD STREET 2: SUITE 410 CITY: COLUMBUS STATE: OH ZIP: 43210 D 1 primary_doc.xml X0708 D LIVE 0002115406 ADVAC Therapeutics Inc 2281 Kenny Road SUITE 410 Columus OH OHIO 43210 9082853087 DELAWARE None None Corporation true 2022 Mark Walter Gossett 2281 Kenny Road Suite 410 Columbus OH OHIO 43210 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2026-02-06 true true false 0 5000000 500000 4500000 true 0 1 0 0 0 false ADVAC Therapeutics Inc /s/ Mark Walter Gossett Mark Walter Gossett President and CEO 2026-03-10